About

LANGaware is a health- and deep-tech startup providing the right solution for the early, efficient, fast, objective and accurate detection of neurodegenerative and psychiatric diseases. LANGaware offers easy, affordable, accurate, and early diagnosis of neurodegenerative and psychiatric diseases and monitoring of one’s cognitive changes and disease progress over time.

Solution & Product

Current approaches to diagnosis of neurodegenerative and psychiatric diseases are time-consuming, cost-ineffective and subjective. A solution is required that will allow for an early, accurate and fast diagnosis. Our disruptive solution uses above and beyond state-of-the-art Artificial Intelligence and Machine Learning methods to detect and monitor universal digital biomarkers based on language, speech and voice. Our solution is mature: it has been extensively and successfully validated for prevention, early detection of cognitive decline and for monitoring to track cognitive changes over time.

Innovation & Scalability

The LANGaware platform has been designed from the ground up to be highly scalable both on the backend and Machine Learning and Artificial Intelligence modeling. The algorithms used improve as more data are ingested and the infrastructure has been built on top of scalable technologies that enable to elastically increase the processing power as more data get in. The LANGaware platform is already designed to be multi-modal, leveraging features extracted from language and speech, and can easily be extended with additional data from connected devices. The LANGaware platform offers a flexible API that allows it to collect data from various sources. It is developed in a way that it can easily recognize a number of data formats internally, thus taking this burden off the source system, reassuring interoperability.

Traction & achievements

We have already booked deals with healthcare centers and big pharmaceutical companies.

Team & Why Us

Our strategy involves the entering of LANGaware to the pharmaceutical industry in Europe, then in the US. Then we are then planning to enter the health care system both in Europe and in the US.

Funding Needs

Our funding needs currently are ~2-3M as a bridge round.